INPERSOL: PERITONEAL DIALYSIS SOLUTION.
The PERITONEAL DIALYSIS SOLUTION is a the manufacturer industrial component. Key specifications include administration: INTRAPERITONEAL, special_features: WITH SYSTEM 3 ADMINISTRATION SET, features_provided: STERILE, primary_container_type: BAG, PLASTIC, primary_container_content_quantity: 2000.000 MILLILITERS. This part is cataloged in the U.S.
Government catalog under NSN 6505-01-169-7803, indicating validated use in U.S. government and defense logistics supply chains. Available through authorized enterprise resellers and TPM (Third Party Maintenance) channels.
Verify compatibility with your specific system configuration before ordering.
| administration | INTRAPERITONEAL |
| special_features | WITH SYSTEM 3 ADMINISTRATION SET |
| features_provided | STERILE |
| primary_container_type | BAG, PLASTIC |
| total_primary_container_quantity | 6 |
| primary_container_content_quantity | 2000.000 MILLILITERS |
| NSN | 6505-01-169-7803 |
| ADMINISTRATION | INTRAPERITONEAL |
| PRIMARY CONTAINER CONTENT QUANTITY | 2000.000 MILLILITERS |
| FEATURES PROVIDED | STERILE |
| PRIMARY CONTAINER TYPE | BAG, PLASTIC |
| SPECIAL FEATURES | PARTIALLY FILLED BAG (2000 ML) HAS A TOTAL CAPACITY OF 3000 ML. |
| ACTIVE MEDICAMENT MEDICINAL STRENGTH | 4.250 PERCENTAGE, W/V DEXTROSE ACTIVE INGREDIENT AND 25.700 MILLIGRAMS CALCIUM CHLORIDE, DIHYDRATE ACTIVE INGREDIENT AND 15.200 MILLIGRAMS MAGNESIUM CHLORIDE, HEXAHYDRATE ACTIVE INGREDIENT AND 567.000 MILLIGRAMS SODIUM CHLORIDE ACTIVE INGREDIENT AND 392.000 MILLIGRAMS SODIUM LACTATE, ANHYDROUS ACTIVE INGREDIENT |
No substitute or cross-reference records for this part.